Donald R. Gehlert - Concepedia

Author

Donald R. Gehlert

Also Known As

D R Gehlert, D. Gehlert, D. R. GEHLERT, D. R. Gehlert, D.R Gehlert, D.R. Gehlert, DONALD R. GEHLERT, Donald Gehlert, Donald R Gehlert, Donald R. Gehlert

185

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Utah University of Arizona National Institutes of Health Indiana University – Purdue University Indianapolis

About

Donald R. Gehlert is an author at Eli Lilly (United States) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	101	6.4K
2	Social Sciences	33	50	4K
3	Health Sciences	16	16	871
4	Natural Sciences	3	3	128
5	Engineering	1	1	317

Donald R. Gehlert

128

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Cloning of a Human Receptor of the NPY Receptor Family with High Affinity for Pancreatic Polypeptide and Peptide YY Ingrid Lundell, Anders Blomqvist, Magnus Berglund, Journal of Biological Chemistry EngineeringHuman ReceptorImmunologyGastrointestinal Peptide HormonePeptide Yy	1995	317
Upregulation of Voluntary Alcohol Intake, Behavioral Sensitivity to Stress, and Amygdala Crhr1 Expression Following a History of Dependence Wolfgang H. Sommer, Roberto Rimondini, Anita C. Hansson, Biological Psychiatry Substance AbuseBehavioral SciencesSubstance UsePsychopathologyPsychiatry	2007	315
Corticotrophin Releasing Factor-Induced Synaptic Plasticity in the Amygdala Translates Stress into Emotional Disorders Donald G. Rainnie, Richard Bergeron, Tammy J. Sajdyk, Journal of Neuroscience	2004	294
3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-<i>b</i>]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism Donald R. Gehlert, Andrea Cippitelli, Annika Thorsell, Journal of Neuroscience PsychopharmacologyPharmacotherapyExperimental PharmacologySocial SciencesMolecular Pharmacology	2007	242
Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test Tammy J. Sajdyk, M.Gretchen Vandergriff, Donald R. Gehlert European Journal of Pharmacology NeuropsychologyAffective NeurosciencePsychopharmacologyPsychologySocial Sciences	1999	240
Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism David T. George, Jodi M. Gilman, Jacqueline Hersh, Science	2008	212
Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses Tammy J. Sajdyk, Douglas A. Schober, Donald R. Gehlert, Behavioural Brain Research Neurobiological MechanismStress HormonePsychiatryNeurophysiologyNeurobiological Factor	1999	189
Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study Martin Balslev Jørgensen, Ju ̈rgen Deckert, Donald C. Wright, Brain Research Rat HippocampusMolecular NeuroscienceC-fos Proto-oncogene ExpressionNeuroprotectionNeurology	1989	176
Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain Donald R. Gehlert, Susan L. Gackenheimer, Douglas A. Schober Neuroscience NeurophysiologyNeuroanatomyMedicinePhysiologyNeuropeptide Receptor	1991	172
Distribution of [125I]angiotensin II binding sites in the rat brain: A quantitative autoradiographic study Donald R. Gehlert, Robert C. Speth, James K. Wamsley Neuroscience Quantitative Autoradiographic StudyNeurophysiologyNeuroanatomyMedicinePhysiology	1986	169

Page 1